The Molecular Landscape of Recurrent and Metastatic Head and Neck Cancers: Insights From a Precision Oncology Sequencing Platform.
about
The challenges of tumor genetic diversity.Targeted sequencing of tonsillar and base of tongue cancer and human papillomavirus positive unknown primary of the head and neck reveals prognostic effects of mutated FGFR3.Droplet digital PCR for detection and quantification of circulating tumor DNA in plasma of head and neck cancer patients.Preoperative Tracheostomy Is Associated with Poor Disease-Free Survival in Recurrent Laryngeal Cancer.Genomic sequencing and precision medicine in head and neck cancers.Loss of INK4a/Arf gene enhances ultraviolet radiation-induced cutaneous tumor development.Systemic Treatment in HPV-Induced Recurrent or Metastatic HNSCC.Mutational Landscapes of Smoking-Related Cancers in Caucasians and African Americans: Precision Oncology Perspectives at Wake Forest Baptist Comprehensive Cancer Center.Genetic Mutation and Exosome Signature of Human Papilloma Virus Associated Oropharyngeal Cancer.Improving radiotherapy in cancer treatment: Promises and challenges.Circulating tumor DNA detection in head and neck cancer: evaluation of two different detection approaches.Dosing Three-Drug Combinations That Include Targeted Anti-Cancer Agents: Analysis of 37,763 Patients.Revisiting Expectations in an Era of Precision Oncology.Diffuse Staining for Activated NOTCH1 Correlates With NOTCH1 Mutation Status and Is Associated With Worse Outcome in Adenoid Cystic Carcinoma.TMEM16A/ANO1 Inhibits Apoptosis Via Downregulation of Bim Expression.Development of a personalized therapeutic strategy for ERBB-gene-mutated cancers.Genomic analysis of head and neck cancer cases from two high incidence regions.Head and Neck Cancers Associated with Exposure to the September 11, 2001 World Trade Center Terrorist Attacks.Comprehensive review of genetic factors contributing to head and neck squamous cell carcinoma development in low-risk, nontraditional patients.Leveraging Genomics for Head and Neck Cancer Treatment.Developing Androgen Receptor Targeting for Salivary Gland Cancers.Precision Therapy of Head and Neck Squamous Cell Carcinoma.Personalized oncogenomic analysis of metastatic adenoid cystic carcinoma: using whole-genome sequencing to inform clinical decision-making.Fanconi anemia and homologous recombination gene variants are associated with functional DNA repair defects in vitro and poor outcome in patients with advanced head and neck squamous cell carcinoma.The immune molecular landscape of the B7 and TNFR immunoregulatory ligand-receptor families in head and neck cancer: A comprehensive overview and the immunotherapeutic implications.Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma.Frameshift events predict anti-PD-1/L1 response in head and neck cancer.Genetic rearrangements, hotspot mutations, and microRNA expression in the progression of metastatic adenoid cystic carcinoma of the salivary gland.Fibroblast growth factor receptor 1 and 3 expression is associated with regulatory PI3K/AKT kinase activity, as well as invasion and prognosis, in human laryngeal cancer.The mutational landscape of recurrent versus nonrecurrent human papillomavirus-related oropharyngeal cancer
P2860
Q30241056-89DA24FB-B08C-48C5-80AF-26FD666FE556Q33798848-CEAB80FD-CF0F-4BD4-BEB9-A89064BD2D25Q33814851-530F3DD4-4F9A-47EC-9A3E-075B6D23DC91Q38741345-80ADE2C7-311D-4FEC-B51F-573E35D9403EQ38776454-BE3657E6-44F9-4079-871D-78670C20E435Q38832702-177DD138-587A-49D9-AADE-5BA68CAEDA5CQ38971558-194FB649-7406-40B9-BD33-095B6EC926B1Q40077046-ABCF0DA0-3146-4A8A-8229-7C8CD70B0843Q40255513-A776539A-6D5F-4573-8425-8DAA03CBB7BEQ41899048-FF9D63F8-5167-4C52-9414-1341013D3B79Q42654048-6495FDC8-34FD-43CC-9F6E-7CDA8B3AC669Q45994683-64DC7A13-421D-4999-8695-833D2F3FD6C1Q47606403-75429C93-6E39-4102-8209-F43180A472BEQ47796677-C40B995E-6037-4C5F-9D3C-4FB8CE66E94CQ47814662-7A2AF417-5298-432A-B282-530CF4EA8D9BQ48138303-81279598-777B-4335-8F13-2DD58DB22717Q48149825-07E9563D-878B-454F-8095-1F599EBEFA07Q48169776-FE81065C-3D92-4979-B72D-AC2C83F02E80Q50087551-5C800284-A474-4E31-A9C3-B269D3BA1702Q50116331-34A76992-6DD8-443E-92AE-D388088F1F9FQ50132910-A13C0E8A-8E0C-4676-98FF-D2479B13A400Q52591781-4121BDF3-2C3A-4A4D-86BF-A250CB8D79D7Q52611827-DDF5B95A-8A21-4387-A187-F8261F575530Q52714606-8E988999-74F3-4F50-BB47-3E79BDE2D7EAQ53359622-053AB7C7-7F1C-4691-B925-6C25AC22DA16Q53686957-CB5633BA-E435-440D-87DB-0D7B868A9C44Q54269200-9F05EE96-C80B-49FD-BB3A-ECD13CD1F7F5Q54955768-50AF8ABE-70AF-4F48-A227-8EEC2006F821Q54985778-8AD34743-DBF2-4F9C-9BFC-93432248F95FQ57174763-39D37082-BEAA-488D-B09F-CC8EDED6249B
P2860
The Molecular Landscape of Recurrent and Metastatic Head and Neck Cancers: Insights From a Precision Oncology Sequencing Platform.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
The Molecular Landscape of Rec ...... Oncology Sequencing Platform.
@en
type
label
The Molecular Landscape of Rec ...... Oncology Sequencing Platform.
@en
prefLabel
The Molecular Landscape of Rec ...... Oncology Sequencing Platform.
@en
P2093
P2860
P1433
P1476
The Molecular Landscape of Rec ...... n Oncology Sequencing Platform
@en
P2093
Ahmet Zehir
Ashok R Shaha
Benjamin R Roman
Bhuvanesh Singh
Christopher A Barker
David B Solit
David G Pfister
David M Hyman
Debyani Chakravarty
P2860
P304
P356
10.1001/JAMAONCOL.2016.1790
P50
P577
2017-02-01T00:00:00Z